Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions.
about
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancerCyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin miceNew Insights into the Pathogenesis of Alcohol-Induced ER Stress and Liver DiseasesVasohibin‑2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor‑2 and growth/differentiation factor‑15 expressionKi67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaKinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesisCyclin D1 determines mitochondrial function in vivo.A comparison of clinicopathological features and molecular markers in british and nigerian women with breast cancerKi-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease CohortProlactin promotes mammary pathogenesis independently from cyclin D1.Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.The cyclin D1b splice variant: an old oncogene learns new tricks.Association of cyclin D and estrogen receptor α36 with hepatocellular adenomas of female mice under chronic endoplasmic reticulum stress.Cyclins and cell cycle control in cancer and disease.ER and PR signaling nodes during mammary gland development.LKB1 catalytic activity contributes to estrogen receptor alpha signalingLonger survival in patients with breast cancer with cyclin d1 over-expression after tumor recurrence: longer, but occupied with diseaseCorrelation between Ki67 and breast cancer prognosis.Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present.Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer.Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation.Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency.Assessment of the hamster cheek pouch as a model for radiation-induced oral mucositis, and evaluation of the protective effects of keratinocyte growth factor using this model.Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer.Role of cyclins D1 and D3 in vestibular schwannoma.
P2860
Q24553135-957023A6-1C5F-4716-A04D-041F1DC00C8AQ28510765-E959685C-6B16-4932-A731-04E61F68AD5DQ33608283-447B0D86-C52C-490B-AAD7-CAE8DDAD937AQ33891210-9EB48483-CACD-4D2B-87E3-6B065E026056Q33932379-B9F6E82D-4A58-4E0E-8FFA-C2D61538CA88Q34475001-846991A1-8294-4D2E-9741-C31A0219DCA0Q35070938-317F76D6-3E85-4D30-9448-4BCBDC562FACQ35181036-B2E75A8E-FFC0-4887-BD24-0B784EFFCA5BQ35537450-B31B0E9D-9C8A-4D30-9ACC-C086EA21AE63Q36071812-254C06DF-1010-4A56-85F7-B6FE2FBCD5A7Q36076419-FBA1DDEC-7A50-4DF6-92FF-50404257F4A1Q36545151-0A734F81-5E14-4639-B548-42C41C64B8CCQ36644420-AD3F120E-B092-4651-BA74-E4738FB970BBQ36796438-031423BF-0851-4BB2-9F53-0AB35E54B10CQ36924384-1FFFC7CE-69E9-45BF-9883-0667EF939E5BQ37207745-2E92BF1E-BE81-475D-9370-5EF62A653248Q37705398-76FC7E32-A278-4116-957E-26764E0626A2Q38077896-FCFFBE91-AFB8-486F-9E71-974E33224911Q38175443-3448BCD6-F806-4CEE-B22B-E9AC292D530FQ38452330-764D73C5-12CB-40FA-8F40-EC72D0FD3720Q40302213-282B20BB-A608-4E95-911D-936C0C19B460Q41863956-5D18FE84-FCC9-4CD3-A27F-664C8F83D9B7Q51748752-B7FE4E71-C3A3-4915-8DD1-1434F2F82485Q52877460-AB06834A-4A89-40EE-8AB8-BA7C2B298D8EQ52931721-9C073BC9-A3D9-4DB5-992F-FF131557CA0D
P2860
Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Immunodetectable cyclin D(1)is ...... d precancerous breast lesions.
@ast
Immunodetectable cyclin D(1)is ...... d precancerous breast lesions.
@en
type
label
Immunodetectable cyclin D(1)is ...... d precancerous breast lesions.
@ast
Immunodetectable cyclin D(1)is ...... d precancerous breast lesions.
@en
prefLabel
Immunodetectable cyclin D(1)is ...... d precancerous breast lesions.
@ast
Immunodetectable cyclin D(1)is ...... d precancerous breast lesions.
@en
P2093
P2860
P356
P1476
Immunodetectable cyclin D(1)is ...... d precancerous breast lesions.
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2001.1705
P407
P577
2001-04-01T00:00:00Z
P5875
P6179
1029600784